Sanofi-GSK hopes to get approvals by the end of this year after early-stage results showed the vaccine produces a robust immune response. Europe’s drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and the UK’s GlaxoSmithKline, the fifth shot …
Read More »Global quest underway to speed COVID-19 vaccine trials
Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection …
Read More »EU finds potential link between heart inflammation and mRNA COVID shots
Europe’s drug regulator has found a possible link between very rare heart inflammation and COVID-19 vaccines from Pfizer-BioNTech and Moderna, it said on Friday. The conditions, myocarditis and pericarditis, must be listed as side-effects of the two mRNA vaccines, the safety committee of the European Medicines Agency (EMA) said, adding …
Read More »Taiwan accuses US of causing ‘unnecessary speculation’ after White House deletes Covid-19 donations tweet
Taiwan’s Foreign Ministry has asked the United States to avoid causing “unnecessary speculation or misunderstanding” after the White House Covid-19 Response Team deleted a tweet that contained the island’s flag. Earlier this week, the White House coronavirus taskforce posted a tweet that showed the flags of nations receiving donations of …
Read More »Germany recommends combining AstraZeneca, mRNA shots
Authorities are trying to increase the speed and effectiveness of vaccinations as the highly infectious Delta variant spreads. Germany is recommending that all people who get a first shot of the AstraZeneca coronavirus vaccine switch to a different type of vaccine for their second shot. The aim is to increase …
Read More »Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds
Immune cells are still organizing to fight the coronavirus months after inoculation, scientists reported. The vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect against the coronavirus for years, scientists reported on Monday. The findings add to growing evidence that most …
Read More »A warning will be issued about rare heart inflammation related to Pfizer, Moderna vaccines, says FDA
The US Food and Drug Administration said on Wednesday it plans to move quickly to add a warning about rare cases of heart inflammation in adolescents and young adults to fact sheets for the Pfizer/BioNTech and Moderna vaccines.
Read More »Egypt opens up to vaccinated tourists without need for Covid-19 test
Cairo has said it will allow travelers to visit the country without providing a negative PCR test, as long as they have been inoculated with vaccines approved by the World Health Organization and the Egyptian Medicines Authority.
Read More »AstraZeneca shots should be halted for over-60s too – EMA official
Countries should also avoid giving the Astrazeneca coronavirus vaccine to people over 60, the head of the EU drug regulator’s COVID-19 task force was quoted on Sunday as saying, amid fears over rare blood clotting and as more vaccines become available. The European Medicines Agency (EMA) considers the Astrazeneca shot …
Read More »Moderna says its COVID-19 vaccine found safe, effective in teens
Moderna’s COVID-19 vaccine was shown to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial, the developer said on Tuesday, potentially setting the stage for a second vaccine for school-aged children to be authorized in July. Moderna Inc, whose vaccine is …
Read More »Mixing Pfizer and AstraZeneca vaccines safe, but increases side effects: Lancet study
Findings at this stage of study focus on reactions to the vaccine, not efficacy Mixing the doses of different types of two-dose coronavirus vaccines has been found to be safe but increased the frequency of mild to moderate symptoms, a new UK study has found. The COM-COV study, led by …
Read More »Vaccine nationalism threatens global efforts race to stop coronavirus – WHO
The World Health Organization warned governments against “vaccine nationalism” on Thursday and urged leaders to make plans now on how to share life-saving inoculations against coronavirus. WHO Director-General Dr. Tedros Adhanom Ghebreyesus said the threat of COVID-19 can only be snuffed out with global coordination — especially when a vaccine …
Read More »Moderna gets further $472 million U.S. award for coronavirus vaccine development
Moderna Inc said on Sunday it has received an additional $472 million from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support the development of its novel coronavirus vaccine. The U.S.-based drugmaker said the additional funding will support its late-stage clinical development including the expanded Phase 3 …
Read More »EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines, sources say
The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi, and Johnson & Johnson and biotech firms BioNtech and CureVac, two EU sources told Reuters. The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of …
Read More »Moderna’s coronavirus vaccine ready to advance to final phase of testing
The first COVID-19 vaccine tested in the U.S. revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday. The shots are poised to begin key final testing. “No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease …
Read More »Novavax awarded $1.6 billion for coronavirus vaccine
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization, and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. Novavax shares jumped 35% in premarket trade. The award is the biggest yet from “Operation …
Read More »COVID-19: BioNTech and Pfizer vaccine shows potential in early human trials
A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday. The drug is one of 17 being tested on humans in a frantic global race to find …
Read More »Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of COVID-19 Vaccine
Moderna Inc said on Thursday it was partnering with contract drugmaker Catalent Inc to prepare an initial 100 million doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. Catalent will fill and package doses, support production, and provide additional staffing for around-the-clock …
Read More »Coronavirus Vaccine Trial by Moderna Shows Promising Early Results
The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the virus, its manufacturer, Moderna announced on Monday. The findings are based on results from the first eight people who each received two doses of the vaccine, starting in …
Read More »